When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

Treatment uses electric pulses to kill prostate cancer cells while minimising risks of incontinence and sexual dysfunction.

Donald Patrick McDonnell, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

AdvanCell is developing therapies to treat cancers including: prostate, skin, pancreatic, breast, bladder, colorectal, kidney ...

The Scientific Review Committee (SRC) charter is to review the safety data from the patients treated in the Phase I portion ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

This year's commemoration of World Cancer Day offers a three-year journey to raise awareness about one of the world’s biggest ...

The trial will enroll 80 patients and aims to determine if opaganib can enhance the effectiveness of darolutamide, a treatment for prostate cancer which often develops resistance to standard care.

Opens in a new tab or window An implantable microdevice safely delivered multiple drugs directly into prostate cancer lesions, enabling assessment of tumor-specific responses. All 14 patients ...